Surefire collects $16.4M to expand cancer-drug catheter biz

Colorado startup Surefire Medical picked up $16.4 million from 30 investors to support expansion of its operations, according to a report in the Denver Business Journal. The four-year-old startup develops cancer-drug delivering catheters, which are designed to administer treatment directly to tumors through a process called chemoembolization. The device gained FDA approval in 2011 and a CE mark this year. The Journal reports that Surefire offered to sell as much as $21.3 million in equity. Article

Suggested Articles

Xeris bucked pandemic trends with the July launch of its Gvoke HypoPen for hypoglycemia, boosting glucagon prescriptions across the board.

Chiasma's new acromegaly pill Mycapssa, aiming to convert patients from injectables, turned out positive 48-week data from an extension study.

Medicated chewing gum is a prime drug delivery target, but it's tough to test. An experimental set of robot jaws could ease that burden.